Filana Therapeutics, Inc. Stock Issued During Period, Value, Stock Options Exercised
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-06-30 was $0.00, a 100.00% decline year-over-year.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2025-03-31 was $90.00K.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2024-06-30 was $101.39M, a 11305.17% increase year-over-year.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for the quarter ending 2023-09-30 was $464.00K, a 241.18% increase year-over-year.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2025 was $90.00K, a 90.20% decline from fiscal 2024.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2024 was $918.00K, a 64.14% decline from fiscal 2023.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2023 was $2.56M, a 438.95% increase from fiscal 2022.
- Filana Therapeutics, Inc. stock issued during period, value, stock options exercised for fiscal 2022 was $475.00K, a 73.96% decline from fiscal 2021.
| Period end | Stock Issued During Period, Value, Stock Options Exercised 3 month | Stock Issued During Period, Value, Stock Options Exercised 12 month |
|---|---|---|
| 2025-12-31 | $90.00K 10-K · filed 2026-03-12 | |
| 2025-06-30 | $0.00 10-Q · filed 2025-11-12 | |
| 2025-03-31 | $90.00K 10-Q · filed 2026-05-07 | |
| 2024-12-31 | $918.00K 10-K · filed 2026-03-12 | |
| 2024-06-30 | $101.39M 10-Q · filed 2025-11-12 | |
| 2023-12-31 | $2.56M 10-K · filed 2026-03-12 | |
| 2023-09-30 | $464.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $889.00K 10-Q · filed 2024-11-07 | |
| 2023-03-31 | $64.00K 10-Q · filed 2024-11-07 | |
| 2022-12-31 | $475.00K 10-K · filed 2025-03-03 | |
| 2022-09-30 | $136.00K 10-Q · filed 2023-11-07 | |
| 2022-06-30 | $119.00K 10-Q · filed 2023-11-07 | |
| 2022-03-31 | $211.00K 10-Q · filed 2023-11-07 | |
| 2021-12-31 | $1.82M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $75.00K 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $3.00K 10-Q · filed 2022-11-07 | |
| 2021-03-31 | $692.00K 10-Q · filed 2022-11-07 | |
| 2020-12-31 | $256.00K 10-K · filed 2023-02-28 | |
| 2020-09-30 | $256.00K 10-Q · filed 2021-11-15 | |
| 2014-12-31 | $379.00K 10-K · filed 2017-03-07 | |
| 2013-12-31 | $492.00K 10-K · filed 2014-02-05 | |
| 2012-12-31 | -$366.00K 10-K · filed 2014-02-05 | |
| 2011-12-31 | $8.91M 10-K · filed 2014-02-05 | |
| 2010-12-31 | $1.94M 10-K · filed 2013-02-08 | |
| 2009-12-31 | $436.00K 10-K · filed 2012-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |